10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,078,051 | -31.2% | 50,377 | -6.9% | 0.01% | -30.0% |
| Q2 2023 | $3,020,274 | +9.6% | 54,088 | +9.5% | 0.01% | 0.0% |
| Q1 2023 | $2,756,919 | +19.7% | 49,416 | -21.8% | 0.01% | +11.1% |
| Q4 2022 | $2,303,773 | +27.9% | 63,221 | 0.0% | 0.01% | +28.6% |
| Q3 2022 | $1,801,000 | -29.3% | 63,221 | +12.2% | 0.01% | -30.0% |
| Q2 2022 | $2,549,000 | -32.7% | 56,330 | +13.1% | 0.01% | -16.7% |
| Q1 2022 | $3,790,000 | -45.4% | 49,823 | +6.9% | 0.01% | -40.0% |
| Q4 2021 | $6,942,000 | +5.5% | 46,601 | +3.1% | 0.02% | 0.0% |
| Q3 2021 | $6,582,000 | -25.2% | 45,210 | +0.6% | 0.02% | -31.0% |
| Q2 2021 | $8,801,000 | +22.6% | 44,942 | +13.3% | 0.03% | +16.0% |
| Q1 2021 | $7,180,000 | +166.9% | 39,666 | +108.8% | 0.02% | +150.0% |
| Q4 2020 | $2,690,000 | – | 19,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |